Keeping high model for end-stage liver disease score liver transplantation candidates alive

Jacqueline G O'Leary; Susan L Orloff; Josh Levitsky; Paul Martin; David P Foley

doi:10.1002/lt.24329

Keeping high model for end-stage liver disease score liver transplantation candidates alive

Liver Transpl. 2015 Nov;21(11):1428-37. doi: 10.1002/lt.24329.

Authors

Jacqueline G O'Leary^{1

2}, Susan L Orloff^{2

3}, Josh Levitsky^{2

4}, Paul Martin^{2

5}, David P Foley^{2

6

7}

Affiliations

¹ Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX.
² Liver Intestine Community of Practice, American Society of Transplantation, Mount Laurel, NJ.
³ Department of Surgery, Oregon Health and Sciences University, Portland, OR.
⁴ Comprehensive Transplant Center, Feinberg School of Medicine, Northwestern University, Chicago, IL.
⁵ Department of Medicine, University of Miami School of Medicine, Miami, FL.
⁶ Department of Surgery, School of Medicine and Public Health, University of Wisconsin, Madison, WI.
⁷ Veterans Administration Surgical Services, William S. Middleton Memorial Hospital, Madison, WI.

PMID: 26335696
DOI: 10.1002/lt.24329

Abstract

As the mean Model for End-Stage Liver Disease (MELD) score at time of liver transplantation continues to increase, it is crucial to implement preemptive strategies to reduce wait-list mortality. We review the most common complications that arise in patients with a high MELD score in an effort to highlight strategies that can maximize survival and successful transplantation.

Publication types

Review

MeSH terms

End Stage Liver Disease / diagnosis
End Stage Liver Disease / surgery*
Global Health
Graft Survival
Humans
Liver Transplantation*
Models, Theoretical*
Risk Assessment / methods*
Risk Factors
Severity of Illness Index
Survival Rate / trends
Time Factors
Waiting Lists / mortality*